DE3431058C2 - - Google Patents

Info

Publication number
DE3431058C2
DE3431058C2 DE3431058A DE3431058A DE3431058C2 DE 3431058 C2 DE3431058 C2 DE 3431058C2 DE 3431058 A DE3431058 A DE 3431058A DE 3431058 A DE3431058 A DE 3431058A DE 3431058 C2 DE3431058 C2 DE 3431058C2
Authority
DE
Germany
Prior art keywords
rde
endotoxin
spp
composition
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3431058A
Other languages
German (de)
English (en)
Other versions
DE3431058A1 (de
Inventor
Edgar Ernst Hamilton Mont. Us Ribi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ribi Immunochem Research Inc
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of DE3431058A1 publication Critical patent/DE3431058A1/de
Application granted granted Critical
Publication of DE3431058C2 publication Critical patent/DE3431058C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE19843431058 1983-08-26 1984-08-23 Gereinigtes, entgiftetes endotoxin Granted DE3431058A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52696783A 1983-08-26 1983-08-26

Publications (2)

Publication Number Publication Date
DE3431058A1 DE3431058A1 (de) 1985-03-07
DE3431058C2 true DE3431058C2 (cs) 1987-06-11

Family

ID=24099553

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3448164A Expired DE3448164C2 (cs) 1983-08-26 1984-08-23
DE19843431058 Granted DE3431058A1 (de) 1983-08-26 1984-08-23 Gereinigtes, entgiftetes endotoxin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE3448164A Expired DE3448164C2 (cs) 1983-08-26 1984-08-23

Country Status (22)

Country Link
JP (1) JPS6072825A (cs)
KR (1) KR880002223B1 (cs)
AT (1) AT389228B (cs)
AU (1) AU554039B2 (cs)
BE (1) BE900377A (cs)
CA (1) CA1225592A (cs)
CH (1) CH660125A5 (cs)
DE (2) DE3448164C2 (cs)
DK (1) DK389384A (cs)
ES (1) ES8606883A1 (cs)
FI (1) FI843204L (cs)
FR (1) FR2550945B1 (cs)
GB (1) GB2147806B (cs)
HU (1) HU191713B (cs)
IL (1) IL72675A (cs)
IN (1) IN157910B (cs)
IT (1) IT1177974B (cs)
NL (1) NL192326C (cs)
NO (1) NO843243L (cs)
NZ (1) NZ209233A (cs)
SE (1) SE8404090L (cs)
ZA (1) ZA846309B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629722A (en) * 1984-07-12 1986-12-16 Ribi Immunochem Research, Inc. Method of inhibiting the onset of acute radiation syndrome
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
DE10115310A1 (de) * 2001-03-28 2002-10-10 Nodar A Daniela Bakteriophagen-Präparation
KR100868443B1 (ko) * 2002-05-27 2008-11-11 주식회사 포스코 폭과 길이가 가변 조정되는 런치박스 제작장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2160326B1 (cs) * 1971-11-19 1975-02-07 Anvar
BE793260A (fr) * 1971-12-24 1973-06-22 Pasteur Institut Agent immunostimulant, medicaments le contenant et procede de fabrication de cet agent immunostimulant
JPS5132794A (en) * 1974-06-20 1976-03-19 Anvar Koshuyokoirusu oyobi ajubantokatsuseiojusuru maikobakuteriumufurakushonnoseiseiho
FR2393065A1 (fr) * 1977-05-31 1978-12-29 Merieux Inst Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product

Also Published As

Publication number Publication date
IN157910B (cs) 1986-07-19
JPH0556326B2 (cs) 1993-08-19
ATA273384A (de) 1989-04-15
FI843204A7 (fi) 1985-02-27
AU554039B2 (en) 1986-08-07
ES535124A0 (es) 1986-05-01
SE8404090L (sv) 1985-02-27
FI843204L (fi) 1985-02-27
JPS6072825A (ja) 1985-04-24
ES8606883A1 (es) 1986-05-01
HUT34887A (en) 1985-05-28
NL8402515A (nl) 1985-03-18
IL72675A (en) 1988-04-29
FI843204A0 (fi) 1984-08-14
KR850001696A (ko) 1985-04-01
SE8404090D0 (sv) 1984-08-14
NZ209233A (en) 1987-11-27
DK389384D0 (da) 1984-08-13
ZA846309B (en) 1985-03-27
NL192326B (nl) 1997-02-03
IT8448757A0 (it) 1984-08-24
FR2550945B1 (fr) 1988-09-16
NL192326C (nl) 1997-06-04
CH660125A5 (de) 1987-03-31
IT1177974B (it) 1987-09-03
KR880002223B1 (ko) 1988-10-20
GB2147806A (en) 1985-05-22
AT389228B (de) 1989-11-10
FR2550945A1 (fr) 1985-03-01
DK389384A (da) 1985-02-27
CA1225592A (en) 1987-08-18
DE3448164C2 (cs) 1987-06-25
NO843243L (no) 1985-02-27
IT8448757A1 (it) 1986-02-24
GB8420612D0 (en) 1984-09-19
BE900377A (fr) 1985-02-18
AU3221584A (en) 1985-02-28
DE3431058A1 (de) 1985-03-07
IL72675A0 (en) 1984-11-30
GB2147806B (en) 1986-10-22
HU191713B (en) 1987-03-30

Similar Documents

Publication Publication Date Title
DE3921416C2 (de) Modifizierte Lipopolysaccharide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
DE3318569C2 (cs)
DE3318567C2 (de) Therapeutisches Mittel, enthaltend gereinigtes, entgiftetes Endotoxin, Zellwandgerüst und Trehalosedimycolat
DE2954387C2 (de) Die tumorspezifische Immunität vergrößernder Bakterienzellenextrakt und Verfahren zu seiner Herstellung
DE3331003C2 (de) Verfahren zur Stabilisierung des Tumor-Nekrose-Faktors und diesen enthaltende wäßrige Lösung oder Pulversubstanz
DE3318568C2 (de) Therapeutische Zusammensetzung zur Bekämpfung von Tumoren enthaltend gereinigtes, entgiftetes Endotoxin, Trehalosedimycolat und ein mit Azeton ausgefälltes Nebenprodukt von mit Chloroform-Methanol extrahierten endotoxischen Glykolipiden
DE69937343T2 (de) Adjuvanszusammensetzung und methoden zu deren verwendung
DE68929318T2 (de) Legionellosis-Impfstoffe und Verfahren zur deren Herstellung
DE3434766C2 (de) Pharmazeutisches Präparat
DE3407823C2 (cs)
DE2331144A1 (de) Wasserloesliche extrakte von mycobacterien
DE3712768A1 (de) Immunologisches adjuvans fuer polysaccharid-impfstoffe
DE2747379A1 (de) P-amino-phenyl-n-acetyl-muramyl-l- alanyl-d-isoglutamin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel
DE2519938A1 (de) Extrakte von corynebakterien, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen
DE2547105A1 (de) N-acetyl-muramyl-l-alanyl-d-isoglutamin enthaltende oelfreie adjuvanzien
DE3431058C2 (cs)
DE2262427C3 (de) Immunostimulierendes Mittel
DE69810024T2 (de) Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten
DE69231724T2 (de) Fischimpfstoff gegen infektion mit aeromonas salmonicida
DE60213785T2 (de) Saponin inaktivierte mykoplasma impfstoffe
EP0187286A1 (de) Öladjuvierte Vaccine und Verfahren zu ihrer Herstellung
EP0343544A2 (de) Immunstimulierendes Mittel aus Propionibakterien sowie Verfahren zur Herstellung desselben
DE3323093A1 (de) Pharmazeutisches praeparat
EP0271447B1 (de) Vorbeugende Massnahmen zur Verhinderung der "Komplexen Respiratorischen Erkrankung bei Rindern" durch Verabreichung von Interferon
DE2161344C3 (de) Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3448164

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3448164

AH Division in

Ref country code: DE

Ref document number: 3448164

Format of ref document f/p: P

D2 Grant after examination
AH Division in

Ref country code: DE

Ref document number: 3448164

Format of ref document f/p: P

8364 No opposition during term of opposition